Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02851368 · ClinicalTrials.gov registry record · Early Phase 1
Near Infrared Fluorescence Imaging With Indocyanine Green
A Early Phase 1 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 25
- Enrollment target
NCT02851368 is a Early Phase 1 study that has completed, run by University of Pittsburgh. The registered enrollment target is 25 participants.
The verdict
NCT02851368, a Early Phase 1 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
This research study will evaluate how Near Infrared Fluorescence imaging (NIFI) with indocyanine green (ICG) contrast dye can assist in the identification and diagnosis of lung nodules during surgery. NIFI is an intraoperative imaging technology that utilizes a coupled camera/fluorophore (ICG) system to fluoresce tissues of interest. Intravenous ICG is a fluorophore with a long-standing high safety profile.
Interventions
- DRUG Indocyanine Green
- DEVICE near infrared fluorescence imaging (NIFI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2016-11 |
| Est. Completion | 2017-11 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02851368
The ClinicalTrials.gov registry entry for NCT02851368 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Indocyanine Green is the first listed.
NCT02851368 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02851368 about?
NCT02851368 is a clinical study titled "Near Infrared Fluorescence Imaging With Indocyanine Green". This research study will evaluate how Near Infrared Fluorescence imaging (NIFI) with indocyanine green (ICG) contrast dye can assist in the identification and diagnosis of lung nodules during surgery. NIFI is an intraoperative imaging technology that utilizes a coupled camera/fluorophore (ICG) syste...
What is the current status of trial NCT02851368?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 25 participants. The study started on 2016-11. Estimated completion is 2017-11.
What interventions are being tested in trial NCT02851368?
The interventions under investigation include: Indocyanine Green (DRUG), near infrared fluorescence imaging (NIFI) (DEVICE).
Who is sponsoring clinical trial NCT02851368?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.